Vocxi Health is closer than ever to launching a handheld breath test that uses graphene nanosensors to detect asymptomatic cancer.
University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the ...
About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...
Abstract: Lung cancer continues to be a leading cause of cancer-related mortality globally, primarily due to late-stage diagnosis. Non-invasive diagnostic techniques, especially those based on exhaled ...
The Essentia Health-Duluth Clinic is improving lung cancer detection through a new cutting-edge robot system and the expansion of a specialty clinic dedicated to early lung cancer detection and ...
2 University of Leeds Leeds Institute of Health Sciences, Leeds, UK Background Lung cancer screening is effective for people at higher risk of the disease, but there is no international consensus on ...
1 Department of Software Engineering, University of Engineering and Technology-Taxila, Taxila, Pakistan 2 Information Systems Department, College of Computer and Information Sciences, Imam Mohammad ...
Abstract: Lung cancer is a global clinical issue and a major cause of cancer-related death. Early detection is of prime concern to enhance patient outcomes. However, symptoms often appear only in ...
Hosted on MSN
How a simple blood test changed cancer detection
Cancer was hardest to defeat because it stayed invisible for too long. This breakthrough showed how tiny biological signals in the blood revealed cancer long before symptoms appeared. Using advanced ...
Background: Several studies have explored the impact of immune checkpoint inhibitor (ICI)–induced immune-related thyroid dysfunction on the prognosis of patients with lung cancer. However, ...
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results